Immune reconstitution after adefovir dipivoxil therapy in patients with chronic hepatitis B

被引：0
|
作者：
Jiang, Y. -F. [1 ]
Ma, Z. H. -H. [1 ]
Liu, Y. -Y. [1 ]
Wang, F. [1 ]
Xin, G. -J. [1 ]
Wang, B. -Y. [1 ]
Niu, J. -Q. [1 ]
机构：
[1] Jilin Univ, Dept Infect Dis, Changchun 130023, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2008年 / 48卷
关键词：
D O I：
10.1016/S0168-8278(08)60564-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
562
引用
收藏
页码：S211 / S211
页数：1
相关论文
共 50 条
  • [31] Long-term therapy with adefovir dipivoxil for HBeAg positive chronic hepatitis B: results from 144 weeks adefovir dipivoxil treatment
    You, J.
    Zhuang, L.
    Chen, H. Y.
    Feng, X.
    Kong, L.
    Lei, H.
    Ma, Y. L.
    Li, Y. L.
    Yang, W. B.
    Huang, J. H.
    Yan, S. M.
    Che, Y. H.
    Wang, Q. Q.
    Chen, L.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S30 - S30
  • [32] Histological improvement in HBeAg positive chronic hepatitis B patients treated with adefovir dipivoxil
    Marcellin, P
    Goodman, Z
    Chang, TT
    Lim, SG
    Tong, MR
    Sievert, W
    Shiffman, M
    Jeffers, L
    Wulfsohn, M
    Fallis, R
    Fry, J
    Brosgart, C
    JOURNAL OF HEPATOLOGY, 2002, 36 : 8 - 8
  • [33] HBsAg seroconversion in adefovir dipivoxil (ADV) treated chronic hepatitis B (CHB) patients
    Shiffman, M
    Marcellin, P
    Jeffers, L
    Gordon, S
    Peters, M
    Rizzetto, M
    Buggisch, P
    Vetter, D
    Choy, GS
    Westland, C
    Arterburn, S
    Currie, G
    Brosgart, CL
    JOURNAL OF HEPATOLOGY, 2004, 40 : 17 - 17
  • [34] Effect of adefovir dipivoxil on T cell immune function in the treatment of chronic hepatitis B and hepatocirrhosis
    Tian, Liting
    Fu, Qilin
    Huang, Fu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (04) : 2511 - 2514
  • [35] Hypophosphatemic Osteomalacia after Low-Dose Adefovir Dipivoxil Therapy for Hepatitis B
    Wong, Tang
    Girgis, Christian M.
    Ngu, Meng C.
    Chen, Roger C. Y.
    Emmett, Louise
    Archer, Katherine A.
    Seibel, Markus J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (02): : 479 - 480
  • [36] RESTORING HEPATITIS B VIRUS-MEDIATED IMMUNE TOLERANCE BY ADEFOVIR DIPIVOXIL AND ENTECAVIR THERAPY
    Jiang Yanfang
    Jin Qinglong
    Yan Hongqing
    Niu Junqi
    HEPATOLOGY, 2009, 50 (04) : 880A - 880A
  • [37] Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance
    Perrillo, Robert P.
    Hann, Hie-Won
    Schiff, Eugene
    Mutimer, David
    Willems, Bernard
    Leung, Nancy
    Lee, William M.
    Dixon, Susan
    Woessner, Mary
    Brosgart, Carol L.
    Condreay, Lynn D.
    Gardner, Stephen D.
    HEPATOLOGY INTERNATIONAL, 2011, 5 (02) : 654 - 663
  • [38] Long-term incidence of adefovir dipivoxil (ADV) resistance in chronic hepatitis B (CHB) patients after 144 weeks of therapy
    Qi, X
    Snow, A
    Thibault, V
    Zhu, Y
    Curtis, M
    Hadziyannis, SJ
    Brosgart, CL
    Currie, G
    Arterburn, S
    Gibbs, CS
    Miller, MD
    Xiong, S
    JOURNAL OF HEPATOLOGY, 2004, 40 : 20 - 21
  • [39] Renal hypophosphatemia and osteomalacia during long-term therapy of adefovir dipivoxil in patients with chronic hepatitis B
    Ye, Qian
    Qu, Yundong
    Wang, Lei
    Liu, Feng
    Qian, Yu
    Wang, Ziyu
    Liu, Qiuxia
    Zhang, Lixin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (01): : 997 - 1003
  • [40] Clinical profile of HBeAg - Chronic hepatitis B patients with adefovir dipivoxil resistance mutations
    Lim, SG
    Hadziyannis, S
    Tassopoulos, N
    Chang, T
    Heathcote, J
    Kitis, G
    Rizzetto, M
    Marcellin, P
    Arterburn, S
    Qi, X
    Brosgart, CL
    Currie, G
    JOURNAL OF HEPATOLOGY, 2005, 42 : 184 - 184
12345